Improving Global Outcomes (KDIGO) group has updated chronic kidney disease treatment guidelines to help slow disease progression in adults. A JAMA article published Wednesday summarized the revised ...

Atopic dermatitis (AD) was associated with an increased risk for chronic kidney disease (CKD) in an Asian population, ...

Healthinote is a smartphone-based toolkit designed to boost patient engagement by providing personalised, trustworthy, and ...

When was the last time you had your blood sugar and blood pressure checked? If you’re a smoker, a drinker, are overweight, ...

New research identifies diabetes as an independent predictor of major adverse cardiovascular events in patients with both ...

Kerendia was originally approved in July 2021 to reduce cardiovascular and kidney complications in patients with chronic ...

North East and North Cumbria NHS has begun a year-long rollout of the Healthinote digital health platform to support patients ...

The environment strongly influences health outcomes, especially in industrialized societies. A new study from the Columbia ...

For patients with psoriasis and Type 2 diabetes, the risk of developing chronic kidney disease (CKD) continued to rise ...

ProKidney Corp. (Nasdaq: PROK) (“ProKidney” or the “Company”), a leading late clinical-stage cellular therapeutics company ...

Shares of ProKidney rose in early trading after it received FDA support for its path to accelerated approval of its rilparencel kidney disease drug. The stock was up 5.4% to $3.89 Tuesday and has more ...

To raise crucial awareness, Fiona Loud, policy director at Kidney Care UK, has highlighted three common kidney problems ...